Skip to content

Application evaluation of virtual reality technology in perioperative education of patients undergoing cerebrovascular stenting

Application evaluation of virtual reality technology in perioperative education of patients undergoing cerebrovascular stenting

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066219
Enrollment
Unknown
Registered
2022-11-28
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Intervention Group:VR preoperative education

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. at least 18 years old; 2. According to the indications of surgery, CAS surgery was performed the next day; 3. The disease was relatively stable and non-acute; 4. Willing to participate in the study and sign the informed consent;

Exclusion criteria

Exclusion criteria: 1. Cognitive impairment, inability to understand and cooperate with the test; 2. Dizziness, headache, vomiting and other symptoms unsuitable for using VR equipment; 3. Audio-visual dysfunction, inability to wear and watch VR videos (such as eye disease); 4. Patients with severe physical dysfunction or strict immobilization;

Design outcomes

Primary

MeasureTime frame
Postoperative anxiety status score;Chronic disease self-efficacy score;

Secondary

MeasureTime frame
Satisfaction with preoperative health education;Incidence of postoperative complications or adverse reactions;VR Immersion scale score;VR equipment adaptability evaluation;Preoperative sleep quality score;

Countries

China

Contacts

Public ContactFeng Ling

Sichuan University/West China Hospital of Sichuan University

fengling216@163.com18980602079

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026